Shivom partnered with Genetic Technologies Limited with the goal of finding unique genetic markers specific to Indian subpopulations that may help explain why the country has one of the highest rising prevalence’s of the type 2 diabetes in the world.
Significantly reduce operational risk and maintenance cost.
The ground-breaking pilot involves patients and local clinics in the south- eastern Indian state of Andhra Pradesh. The process to date involves collecting saliva samples of the patients from which DNA is to be extracted, analysed and secured on Shivom’s blockchain-based genomics datahub. The goal is to develop a tailored diagnostics kit that is suited for the local population in India.